Quantcast Patent Covering The Approved Administration Of Kuvan With Food For The Treatment - Congoo
 
 
WORLD Log In
Patent covering the approved administration of Kuvan with food for the treatment
Have an interest in this Story?
Sign Up for Real-Time email updates
News-Medical.Net  | November 06, 2009

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the United States Patent and Trademark Office has issued a patent covering the approved administration of Kuvan® (sapropterin dihydrochloride) with food for the treatment of phenylketonuria (PKU). The patent expires in 2024. "We belie...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
THENNY MEJIA THENNY MEJIA
Sr. Vice President
Healthcare Industry
Gordon Kauer Gordon Kauer
Sales Rep/News/On Air
Broadcasting Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.